Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population

Lotti Tajouri, Francesca Fernandez, Sophie Tajouri, Geraldine Detriche, Attila L Szvetko, Natalie Colson, Peter A Csurhes, Michael P. Pender, Lyn R. Griffiths

Research output: Contribution to journalArticleResearchpeer-review

5 Citations (Scopus)

Abstract

Multiple Sclerosis (MS) is a central nervous system (CNS) chronic inflammatory demyetinating disease leading to various neurological disabilities. The disorder is more prevalent for women with a ratio of 3:2 female to male. Objectives: To investigate variation within the estrogen receptor 1 (ESR1) polymorphism gene in an Australian MS case-control population using two intragenic restriction fragment length polymorphisms; the G594A located in exon 8 detected with the Btgl restriction enzyme and T938C located in intron 1, detected with PvuII. One hundred and ten Australian MS patients were studied, with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 110 age, sex and ethnicity matched controls were investigated as a comparative group. No significant difference in the allelic distribution frequency was found between the case and control groups for the ESR1 PvuII (P=0.50) and Btg1 (P=0.45) marker. Our results do not support a role for these two ESR1 markers in multiple sclerosis susceptibility, however other markers within ESR1 should not be excluded for potential involvement in the disorder. (c) 2006 Elsevier B.V. All rights reserved.

Original languageEnglish
Pages (from-to)9-12
Number of pages4
JournalJournal of the Neurological Sciences
Volume252
Issue number1
DOIs
Publication statusPublished - 15 Jan 2007
Externally publishedYes

Cite this

Tajouri, Lotti ; Fernandez, Francesca ; Tajouri, Sophie ; Detriche, Geraldine ; Szvetko, Attila L ; Colson, Natalie ; Csurhes, Peter A ; Pender, Michael P. ; Griffiths, Lyn R. / Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population. In: Journal of the Neurological Sciences. 2007 ; Vol. 252, No. 1. pp. 9-12.
@article{0ddcdf2b6f6545c99e508294a9153c16,
title = "Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population",
abstract = "Multiple Sclerosis (MS) is a central nervous system (CNS) chronic inflammatory demyetinating disease leading to various neurological disabilities. The disorder is more prevalent for women with a ratio of 3:2 female to male. Objectives: To investigate variation within the estrogen receptor 1 (ESR1) polymorphism gene in an Australian MS case-control population using two intragenic restriction fragment length polymorphisms; the G594A located in exon 8 detected with the Btgl restriction enzyme and T938C located in intron 1, detected with PvuII. One hundred and ten Australian MS patients were studied, with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 110 age, sex and ethnicity matched controls were investigated as a comparative group. No significant difference in the allelic distribution frequency was found between the case and control groups for the ESR1 PvuII (P=0.50) and Btg1 (P=0.45) marker. Our results do not support a role for these two ESR1 markers in multiple sclerosis susceptibility, however other markers within ESR1 should not be excluded for potential involvement in the disorder. (c) 2006 Elsevier B.V. All rights reserved.",
author = "Lotti Tajouri and Francesca Fernandez and Sophie Tajouri and Geraldine Detriche and Szvetko, {Attila L} and Natalie Colson and Csurhes, {Peter A} and Pender, {Michael P.} and Griffiths, {Lyn R.}",
year = "2007",
month = "1",
day = "15",
doi = "10.1016/j.jns.2006.09.018",
language = "English",
volume = "252",
pages = "9--12",
journal = "World neurology",
issn = "0022-510X",
publisher = "Elsevier",
number = "1",

}

Tajouri, L, Fernandez, F, Tajouri, S, Detriche, G, Szvetko, AL, Colson, N, Csurhes, PA, Pender, MP & Griffiths, LR 2007, 'Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population' Journal of the Neurological Sciences, vol. 252, no. 1, pp. 9-12. https://doi.org/10.1016/j.jns.2006.09.018

Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population. / Tajouri, Lotti; Fernandez, Francesca; Tajouri, Sophie; Detriche, Geraldine; Szvetko, Attila L; Colson, Natalie; Csurhes, Peter A; Pender, Michael P.; Griffiths, Lyn R.

In: Journal of the Neurological Sciences, Vol. 252, No. 1, 15.01.2007, p. 9-12.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Allelic variation investigation of the estrogen receptor within an Australian multiple sclerosis population

AU - Tajouri, Lotti

AU - Fernandez, Francesca

AU - Tajouri, Sophie

AU - Detriche, Geraldine

AU - Szvetko, Attila L

AU - Colson, Natalie

AU - Csurhes, Peter A

AU - Pender, Michael P.

AU - Griffiths, Lyn R.

PY - 2007/1/15

Y1 - 2007/1/15

N2 - Multiple Sclerosis (MS) is a central nervous system (CNS) chronic inflammatory demyetinating disease leading to various neurological disabilities. The disorder is more prevalent for women with a ratio of 3:2 female to male. Objectives: To investigate variation within the estrogen receptor 1 (ESR1) polymorphism gene in an Australian MS case-control population using two intragenic restriction fragment length polymorphisms; the G594A located in exon 8 detected with the Btgl restriction enzyme and T938C located in intron 1, detected with PvuII. One hundred and ten Australian MS patients were studied, with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 110 age, sex and ethnicity matched controls were investigated as a comparative group. No significant difference in the allelic distribution frequency was found between the case and control groups for the ESR1 PvuII (P=0.50) and Btg1 (P=0.45) marker. Our results do not support a role for these two ESR1 markers in multiple sclerosis susceptibility, however other markers within ESR1 should not be excluded for potential involvement in the disorder. (c) 2006 Elsevier B.V. All rights reserved.

AB - Multiple Sclerosis (MS) is a central nervous system (CNS) chronic inflammatory demyetinating disease leading to various neurological disabilities. The disorder is more prevalent for women with a ratio of 3:2 female to male. Objectives: To investigate variation within the estrogen receptor 1 (ESR1) polymorphism gene in an Australian MS case-control population using two intragenic restriction fragment length polymorphisms; the G594A located in exon 8 detected with the Btgl restriction enzyme and T938C located in intron 1, detected with PvuII. One hundred and ten Australian MS patients were studied, with patients classified clinically as Relapsing Remitting MS (RR-MS), Secondary Progressive MS (SP-MS) or Primary Progressive MS (PP-MS). Also, 110 age, sex and ethnicity matched controls were investigated as a comparative group. No significant difference in the allelic distribution frequency was found between the case and control groups for the ESR1 PvuII (P=0.50) and Btg1 (P=0.45) marker. Our results do not support a role for these two ESR1 markers in multiple sclerosis susceptibility, however other markers within ESR1 should not be excluded for potential involvement in the disorder. (c) 2006 Elsevier B.V. All rights reserved.

U2 - 10.1016/j.jns.2006.09.018

DO - 10.1016/j.jns.2006.09.018

M3 - Article

VL - 252

SP - 9

EP - 12

JO - World neurology

JF - World neurology

SN - 0022-510X

IS - 1

ER -